COMP <GO>
BLSH vs CORZ // EV/EBITDA & P/E VALUATION
Bullish (NYSE) VS. Core Scientific Inc. (NASDAQ) • 15-METRIC TALLY: BLSH 0
— CORZ 2
■ METRIC PARITY
LAST: $23.90 (-16.05%) • MKT CAP: $4.54B
valuation
—
LAST: $13.25 (-8.18%) • MKT CAP: $4.64B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BLSH VS. CORZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BLSH | CORZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -9.72% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -37.50% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 5/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.3 | 46.9 | -16.60 | CORZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.12 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 29.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.54B | $4.64B | -$92.0M | CORZ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BLSH REV | CORZ REV | BLSH GROSS % | CORZ GROSS % | BLSH FCF | CORZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $319.0M | — | 11.9% | — | -$450.8M |
| FY 2024 | — | $510.7M | — | 23.7% | — | -$52.1M |
| FY 2023 | — | $502.4M | — | — | — | $42.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BLSH // BETA —
CORZ // BETA 1.12